These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7846315)

  • 1. The exact formula for tumor incidence in the two-stage model.
    Kopp-Schneider A; Portier CJ; Sherman CD
    Risk Anal; 1994 Dec; 14(6):1079-80. PubMed ID: 7846315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the exact hazard and survival functions of the MVK stochastic carcinogenesis model.
    Zheng Q
    Risk Anal; 1994 Dec; 14(6):1081-4. PubMed ID: 7846316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multistage models of carcinogenesis: an approximation for the size and number distribution of late-stage clones.
    Sherman CD; Portier CJ; Kopp-Schneider A
    Risk Anal; 1994 Dec; 14(6):1039-48. PubMed ID: 7846311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exact analysis of the multistage model explaining dose-response concavity.
    Cox LA
    Risk Anal; 1995 Jun; 15(3):359-68. PubMed ID: 7604169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristic patterns of cancer incidence: Epidemiological data, biological theories, and multistage models.
    Hiller J; Vallejo C; Betthauser L; Keesling J
    Prog Biophys Mol Biol; 2017 Mar; 124():41-48. PubMed ID: 27836510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-time distribution of cancer risks to be expected from acute or chronic exposures to general mutagens.
    Pierce DA; Vaeth M
    Radiat Res; 2000 Dec; 154(6):727-8;discussion 730-1. PubMed ID: 11187015
    [No Abstract]   [Full Text] [Related]  

  • 7. Estimating age, period and cohort effects using the multistage model for cancer.
    Holford TR; Zhang Z; McKay LA
    Stat Med; 1994 Jan; 13(1):23-41. PubMed ID: 9061838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing between models of carcinogenesis: the role of clonal expansion.
    Kopp-Schneider A; Portier CJ
    Fundam Appl Toxicol; 1991 Oct; 17(3):601-13. PubMed ID: 1794662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenic risk assessment with time-dependent exposure patterns.
    Murdoch DJ; Krewski D
    Risk Anal; 1988 Dec; 8(4):521-30. PubMed ID: 3244859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The time to tumor approach in risk assessment.
    Albert RE
    Basic Life Sci; 1986; 38():551-6. PubMed ID: 3741347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved approximation to the exact solution of the two-stage clonal growth model of cancer.
    Clewell HJ; Quinn DW; Andersen ME; Conolly RB
    Risk Anal; 1995 Aug; 15(4):467-73. PubMed ID: 7480946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells in chemical carcinogenesis.
    Dietrich C; Weiss C; Bockamp E; Brisken C; Roskams T; Morris R; Oesch-Bartlomowicz B; Oesch F
    Arch Toxicol; 2010 Mar; 84(3):245-51. PubMed ID: 19941131
    [No Abstract]   [Full Text] [Related]  

  • 13. Armitage-Doll two-stage model: implications and extension.
    Chen CW
    Risk Anal; 1993 Jun; 13(3):273-9. PubMed ID: 8341806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of a multistage model that incorporates DNA damage and repair to the analysis of initiation/promotion experiments.
    Kopp-Schneider A; Portier CJ; Rippmann F
    Math Biosci; 1991 Jul; 105(2):139-66. PubMed ID: 1806098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of multiple carcinogens and synergy index.
    Kawaguchi I; Doi M; Kakinuma S; Shimada Y
    J Theor Biol; 2006 Nov; 243(1):143-51. PubMed ID: 16860345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A numerical solution to the nonhomogeneous two-stage MVK model of cancer.
    Crump KS; Subramaniam RP; Van Landingham CB
    Risk Anal; 2005 Aug; 25(4):921-6. PubMed ID: 16268939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A note on the relationship between lifetime tumor risk and expected time to tumor.
    Gaylor DW; Zheng Q
    Risk Anal; 1997 Feb; 17(1):5-7. PubMed ID: 9131823
    [No Abstract]   [Full Text] [Related]  

  • 18. On the parameters of the clonal expansion model.
    Heidenreich WF
    Radiat Environ Biophys; 1996 May; 35(2):127-9. PubMed ID: 8792461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical carcinogenesis. A new approach to the molecular and cellular mechanisms.
    Mekler LB
    Oncology; 1973; 28(1):63-82. PubMed ID: 4593767
    [No Abstract]   [Full Text] [Related]  

  • 20. Chromosome damage and cancer risk in the workplace: the example of cytogenetic surveillance in Croatia.
    Fucić A; Znaor A; Strnad M; van der Hel O; Aleksandrov A; Miskov S; Grah J; Sedlar M; Jazbec AM; Ceppi M; Vermeulen R; Boffetta P; Norppa H; Bonassi S
    Toxicol Lett; 2007 Jul; 172(1-2):4-11. PubMed ID: 17651925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.